Quadrature Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
415,116
+267,802
+182% +$1.44M 0.02% 497
2026
Q1
$794K Sell
147,314
-189,398
-56% -$1.13M 0.01% 638
2025
Q4
$2.34M Buy
+336,712
New +$2.21M 0.02% 338
2025
Q3
Sell
-24,485
Closed -$163K 1062
2025
Q2
$163K Sell
24,485
-46,715
-66% -$240K ﹤0.01% 844
2025
Q1
$464K Buy
+71,200
New +$512K 0.01% 597
2016
Q2
Sell
-28,203
Closed -$741K 519
2016
Q1
$741K Buy
+28,203
New +$2.09M 0.1% 214
2015
Q4
Sell
-13,150
Closed -$2.34M 438
2015
Q3
$2.34M Buy
+13,150
New +$3.07M 0.78% 33

Other funds holding BHC

Quadrature Capital's BHC Position: Q2 2026 in Review

Quadrature Capital increased its Bausch Health (BHC) stake by 182% in Q2 2026, buying an estimated $1.44M and bringing the position to 415,116 shares worth $2.05M. The position accounts for 0.02% of the portfolio, ranked #497.

Quadrature Capital first reported a position in BHC in Q3 2015 and has held it in 7 quarters since. The position peaked at $2.34M in Q4 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Quadrature Capital held 415,116 shares of Bausch Health worth $2.05M as of Q2 2026.
  • Quadrature Capital bought 267,802 Bausch Health shares in Q2 2026, an estimated $1.44M.
  • Bausch Health made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #497 holding.
  • Quadrature Capital first reported a position in Bausch Health in Q3 2015 and has held it in 7 quarters since.
  • Quadrature Capital's Bausch Health position peaked at $2.34M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.